We have seen the alarming headlines and wondered - what can be done to stem or reverse the tide of chronic diseases that have already placed an enormous burden on families, communities, and governments? Furthermore, we recognize the roadblocks in creating new, sorely-needed diagnostic tools and treatments.

In response, the Stetson Family Office is leading a multi-pronged approach to prevention and support for innovation; inspired by the growing evidence-based research that confirms up to one-half of all Alzheimer’s Disease cases and other chronic diseases could be prevented or postponed. This effort is aligned with the UN Sustainable Development Goals – most importantly, SDG#3 in support of Health and Well Being.

Stetson Family Office (SFO), established in 1919, has invested its resources over the last three years to insure “Better Health at Lower Cost” through a global communication strategy, outreach to family offices, establishment of an endowment fund and opportunity to invest in prevention, wellness and life science innovation.

Board of Directors

Chuck Stetson, Stetson Family Office
Eugene Durenard, Stetson Family Office
Chuck Bauer, Former Vice-Chairman, PricewaterhouseCoopers
Joan Koerber-Walker, CEO, Arizona Bioindustry Association
Pamela Newman, AON
Damaris Skouras, CEO of Olatec